| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2575760 | The American Journal of Geriatric Pharmacotherapy | 2011 | 10 Pages |
Abstract
Urinary assays of CYP2D6 phenotype are technically feasible in older individuals with dementia who are taking multiple medications, and may be a useful clinical tool in this population. However, the study was unable to make inferences about an association between CYP2D6 phenotype and galantamine responsiveness.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
Jo-Anne MD, Murray PhD, Inna BMSc, Ute I. MD, David PhD, Monidipa MD, MSc,